Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
7,341 total articles
Joseph Valane, General Counsel and Secretary of Howard Hughes Holdings Inc (HHH), purchased 1,260 shares on March 13, 2026, at $64.4499 per share, an acquisition valued at $81206. After the trade he holds 29,209 shares. The company is trading at a P/E of 11.12 and remained profitable over the last twelve months, according to InvestingPro analysis. …
Director Merchant Fazal F. sold 35,000 shares of Warner Bros. Discovery (WBD) on March 16, 2026, generating roughly $961,800. The sale occurred at prices between $27.48 and $27.49 and leaves Merchant with 95,539 directly held shares. The transaction comes as WBD shares trade close to a 52-week high and amid significant merger-related activity and a…
Canada Pension Plan Investment Board sold 3,500,000 shares of California Resources Corp on March 12, 2026, realizing $213.85 million at $61.1 per share, according to a Form 4 filing. The divestment leaves the pension fund with 7,006,895 directly held CRC shares. California Resources is trading close to its 52-week high and reported mixed fourth-qua…
Extra Space Storage Chief Executive Joseph D. Margolis sold 7,500 shares on March 13, 2026 under a Rule 10b5-1 trading plan, generating $1,065,600. The disposal occurred above the prevailing share price and follows gift transactions earlier in March. The company reported Q4 2025 earnings and revenue that exceeded analyst expectations and drew a hig…
Mineralys Therapeutics' Chief Medical Officer, David Malcom Rodman, executed a planned sale of 20,406 shares on March 12 and 13, 2026, for roughly $542,973 and simultaneously exercised options to acquire 14,057 shares for $102,363. The transactions were completed under a Rule 10b5-1 trading arrangement established in October 2025. The stock trades …
Braden Pamela Joyce, a director at BigBear.ai Holdings, Inc. (NYSE: BBAI), sold 80,000 shares on March 16, 2026, for $4.00 per share, generating $320,000 in proceeds. The company's shares have since slid to $3.95 and are down 34% over six months. BigBear.ai’s fiscal Q4 2025 results showed an EPS beat but a revenue shortfall, and management issued f…
Brittain Miles, Executive Vice President of NWPX Infrastructure, Inc., sold 4,000 shares of company common stock on March 12, 2026, in a transaction valued at $284,040. The sale occurred at a weighted average price of $71.01 per share with execution prices ranging from $70.45 to $73.77. Following the disposition, Miles retains 23,306 shares held di…
Carla J. Peterman, President and EVP Cust & Corp Affairs at PG&E Corp (NYSE: PCG), sold 31,786 shares on March 16, 2026, generating $582,001 in proceeds under a pre-arranged Rule 10b5-1 trading plan adopted December 11, 2025. The company has also sold $2.2 billion of first mortgage bonds across multiple maturities, seen a ratings outlook upgrade by…
Tarbert Heath, president of Circle Internet Group, sold 15,000 Class A shares on March 13, 2026, for $1.74 million under a 10b5-1 trading plan. The transactions, executed at prices between $113.80 and $118.58 per share, occurred as the stock has since reached $125.83, a year-to-date gain of 45.5%. Analyst activity and industry developments around U…
UWM Holdings saw 2,266,322 shares sold by Mat Ishbia and SFS Holding Corp. between March 12 and March 16, 2026, generating about $8.43 million in proceeds. The sales were carried out under a 10b5-1 plan, coinciding with SFS Holding's conversion of 11 million paired interests into Class A common stock and ongoing proxy solicitation for a planned acq…
ReposiTrak Inc. CEO Randall K. Fields disposed of 4,000 shares on March 12, 2026, through a pre-set Rule 10b5-1 plan for a total of $32,239. The transaction occurred while the stock hovered near its 52-week low, and came amid corporate announcements including a quarterly dividend, new patent-pending traceability technology and a deeper strategic ti…
Eugene S Stark, Vice President Administration/CCO/PFO at General American Investors Co Inc (NYSE: GAM), bought 3,000 shares of the company's 5.95% Preferred Stock at $24.95 per share, a transaction valued at $74,850. After the purchase, Stark directly holds 27,000 shares of that preferred issue. The company is noted for 54 consecutive years of divi…
A Vornado Realty Trust director purchased 30,000 common shares on March 12, 2026, for $766,500 as the REIT’s shares trade near a 52-week low. The purchase leaves the director with 215,000 shares directly owned. Vornado’s fourth-quarter 2025 results showed an EPS shortfall and a small revenue beat, underscoring mixed near-term financial signals.
A consortium of American Industrial Partners-related entities reported the sale of 2,545,432 shares of V2X Inc. (VVX) common stock on March 12, 2026, at $68.21 per share, a transaction that generated roughly $173.6 million. The disclosure follows recent volatility in VVX shares and comes amid a quarter in which the company reported earnings and rev…
On Semiconductor executive Sudhir Gopalswamy sold 6,114 shares on March 13, 2026, for $58.67 per share, generating proceeds of $358,708. The sale, recorded on a Form 4, left Gopalswamy with 173,943 shares. Separately, corporate notices and equity actions were reported at Ascendis Pharma, Onsemi, KB Financial Group, Royal Bank of Canada and Webuy Gl…
Kevin Patrick Marchetti, Co-Executive Chairman of Lineage, Inc. (NASDAQ: LINE), purchased 13,300 shares on March 12, 2026 for $498,699. The buy brings his direct stake to 113,690 shares while he also holds substantial indirect positions. The acquisition comes as Lineage reported steady fourth-quarter 2025 revenue and a modest EPS, and as at least o…
Thomas R. Donahue, Federated Hermes' vice president, chief financial officer and treasurer, sold 30,000 shares of Class B common stock on March 13, 2026, in a transaction valued at $1.71 million, according to a recent SEC Form 4 filing. The company also reported fourth-quarter 2025 results that beat estimates while facing legal action in the High C…
Joseph Paul C, Akamai Technologies Inc's Executive Vice President - Global Sales, executed three sales totaling 4,990 shares on March 16, 2026 for approximately $531256 under a Rule 10b5-1 trading plan. The transactions left him with 34,533 directly held shares and 165.196 indirectly held shares via a 401(k). The insider move coincides with Akamai …
Absci Corp's Chief Innovation Officer Andreas Busch purchased 100,000 shares on March 12, 2026, spending $229,000 at $2.29 per share. The insider buy leaves Busch with 421,446 shares directly. The transaction comes as the stock trades near its 52-week low and follows recent clinical data that prompted a program pause and a reduction in analyst opti…
Akamai Technologies reported that Executive Vice President and General Counsel Ahola Aaron sold 4,500 shares of common stock on March 16, 2026, for a total of $478,216 at prices between $106.2463 and $106.37. Following the sale, Ahola retains direct ownership of 29,716 shares, including deferred compensation and trust holdings, plus an indirect hol…
Root, Inc. Chief Administrative Officer Jonathan Allison sold 3,900 Class A shares on March 12, 2026, for $43.61 each, totaling $170,079. The sale was made under a pre-arranged 10b5-1 plan and follows the insurer's Q4 2025 results showing strong revenue growth but a slight decline in net income due to higher operating expenses. Keefe, Bruyette & Wo…
EyePoint Inc. President and CEO Jay S. Duker purchased 1,500 shares of common stock on March 16, 2026, spending $19,723 at an average price of $13.1492 per share. The purchase follows a 16% drop in the prior week while the stock remains up more than 102% over the last 12 months. EyePoint reported weak fourth-quarter 2025 results with a wider-than-e…
Ultralife Corp President and CEO Michael Edward Manna bought 2,000 shares of the company's common stock on March 12, 2026, spending $12,024 across two transactions. The purchases occurred after the stock gained 23% over the prior week and amid a quarterly report that beat on EPS but missed on revenue. InvestingPro lists Ultralife among its Most Und…
Lori Winkler, senior vice president and chief human resources officer at Zimmer Biomet Holdings, sold 2,650 shares on March 12, 2026, generating proceeds of $250,849. The executive retains 10,224 shares after the sale. The transaction arrives amid a fourth-quarter earnings beat, a guarded outlook for 2026, and fresh coverage from William Blair assi…
NeuroOne Medical Technologies (NMTC) Business Development Director Mark Christianson sold 917 shares of company stock on March 12 and 13, 2026, receiving approximately $733. The transactions left him with 214,283 shares. The company reported a Q1 fiscal 2026 net loss of $1.4 million on revenue of $2.9 million, slightly above expectations. Investing…
